About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Phosphagenics Mylan Arbitration Hearing Concluded
November 9, 2017
Click here to read more
Post navigation
Previous Post
Phosphagenics Entitlement Offer Raises Over AUD3M
Next Post
Phosphagenics Provides Update on TPM Propofol Development Program
Related Posts
Phosphagenics Director and Founder Steps Down
July 9, 2015
CEO Update – Teleconference
March 20, 2018
Phosphagenics Reports Positive Resuls for Weaner Pig Efficiency Trial
January 20, 2016